Wedbush Securities’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-524
| Closed | -$2K | – | 1128 |
|
|
2022
Q2 | $2K | Hold |
524
| – | – | ﹤0.01% | 1069 |
|
|
2022
Q1 | $6K | Hold |
524
| – | – | ﹤0.01% | 1096 |
|
|
2021
Q4 | $8K | Sell |
524
-80
| -13% | -$1.22K | ﹤0.01% | 1169 |
|
|
2021
Q3 | $18K | Buy |
604
+204
| +51% | +$6.08K | ﹤0.01% | 1161 |
|
|
2021
Q2 | $14K | Buy |
+400
| New | +$14K | ﹤0.01% | 1154 |
|
|
2020
Q4 | – | Sell |
-84
| Closed | -$11K | – | 1041 |
|
|
2020
Q3 | $11K | Hold |
84
| – | – | ﹤0.01% | 927 |
|
|
2020
Q2 | $14K | Hold |
84
| – | – | ﹤0.01% | 950 |
|
|
2020
Q1 | $12K | Buy |
84
+8
| +11% | +$1.14K | ﹤0.01% | 869 |
|
|
2019
Q4 | $25K | Sell |
76
-29
| -28% | -$9.54K | ﹤0.01% | 980 |
|
|
2019
Q3 | $52K | Sell |
105
-186
| -64% | -$92.1K | 0.01% | 938 |
|
|
2019
Q2 | $177K | Sell |
291
-84
| -22% | -$51.1K | 0.02% | 850 |
|
|
2019
Q1 | $229K | Sell |
375
-39
| -9% | -$23.8K | 0.02% | 714 |
|
|
2018
Q4 | $151K | Buy |
414
+46
| +13% | +$16.8K | 0.02% | 723 |
|
|
2018
Q3 | $249K | Sell |
368
-58
| -14% | -$39.2K | 0.03% | 675 |
|
|
2018
Q2 | $371K | Buy |
+426
| New | +$371K | 0.05% | 477 |
|